Lucid Group (LCID) awards 1M options and 402k RSUs to director
Rhea-AI Filing Summary
Lucid Group, Inc. director Silvio Napoli received new equity awards. He was granted employee stock options covering 1,000,000 shares of Class A common stock at an exercise price of $8.21 per share, expiring on April 15, 2036. He was also granted 402,073 restricted stock units that vest over four years, starting on June 5, 2027. Following these grants, he directly holds 402,073 shares of Class A common stock subject to time-based vesting.
The stock options are performance-based and split into five tranches. Each tranche vests only after both its scheduled time-based vesting date between April 15, 2028 and April 15, 2030 and certification that Lucid has achieved a specified market capitalization hurdle ranging from $5.0 billion to $17.5 billion, assuming Napoli remains employed through each vesting date.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Employee Stock Option (right to buy) | 1,000,000 | $0.00 | -- |
| Grant/Award | Class A Common Stock | 402,073 | $0.00 | -- |
Footnotes (1)
- Represents restricted stock units that will vest over four years, with 1/4th vesting on June 5, 2027 and 1/16th vesting quarterly thereafter in twelve installments, on each March 5, June 5, September 5, and December 5 of each calendar year that occurs following June 5, 2027, subject to the reporting person's continued employment with the Issuer or its subsidiary through each vesting date. Represents performance-based stock options that are divided into five tranches and subject to both time-based and performance-based vesting conditions. A given tranche vests upon the later of (x) the tranche's time-based vesting date (which is April 15, 2028 for tranche 1, April 15, 2029 for tranches 2 and 3 and April 15, 2030 for tranches 4 and 5) and (y) certification of achievement of the market capitalization performance hurdle applicable to the tranche ($5.0 billion, $7.5 billion, $10.0 billion, $12.5 billion, and $17.5 billion for tranches 1,2,3,4, and 5 respectively, calculated in accordance with the reporting person's stock option agreement), in each case, subject to the reporting person's continued employment with the Issuer or its subsidiary through each vesting date.